Patient Home Monitoring | StockChase
166
Patient Home Monitoring (PHM-X)

Last Price Recorded: $0.2900 on 2017-11-16

ON STOCKCHASE SINCE Sep 2013

other services

Patient Home Monitoring



ABOUT CHARTS : These are thumbnail sketches of the stock prices, from the time of the opinions. The charts are not detailed, and are meant only to give an oveview (note the number of datapoints). The charts show one month of information or up to six months if you are a subscriber. Recent opinions will obviously have fewer datapoints then older opinions.


You are not seeing charts because you haven't logged in or haven't opted in

Date Signal Company Opinion Expert
2017-11-15
COMMENT

PHM-X

$0.285

Patient Home Monitoring


Ranks 135 out of 700 stocks. Overall numbers seem reasonable. The latest earnings were slightly negative at -2.4%. Earnings estimates are expected to be $.03, but it is only covered by one analyst. Seems to be expensive.

other services

Robert McWhirter

President

OPTIMISTIC
2017-11-08
COMMENT

PHM-X

$0.315

Patient Home Monitoring


Just announced they were going to be splitting the company. He's been waiting for this for some time. It was probably about a year ago they said they were going to be splitting the company into 2 pieces. They’ve been working with CRA to get everything figured out. They are going to have a shareholders meeting and it is going to be voted on. He is surprised this is trading where it is, but it was probably a function of legacy issues, and is now probably a function of tax loss selling.

other services

Bruce Campbell (2)

President & Portfolio Manager

2017-10-12
HOLD

PHM-X

$0.305

Patient Home Monitoring


It was the ‘go-go’ stock a few years ago and now the one everyone hates.  He gets a lot of calls.  A lot of people are frustrated as they go through restructuring.  They feel they are very close to getting approval to spin the company off into two.  He focuses on pure numbers.  They are fantastic.  They grew their business to make up for the healthcare benefits cuts previously.  The principles there now have a lot of stock that they bought at higher prices.  They are growing organically.  People need to be patient during the restructuring.

other services

Bruce Campbell (2)

President & Portfolio Manager

OPTIMISTIC
2017-09-21
DON'T BUY

PHM-X

$0.310

Patient Home Monitoring


This seems to have been stuck in the $0.25-$0.50 netherworld for the last 3-4 months. It has been banging into a kind of moving average. Chart shows a huge base, and if it ever got its act together, it would probably get a lot of attention. A 1-year chart shows it bottomed at around $0.13-$0.14 followed by a little break out, a little resistance and a slowly falling trend line. Until it got above $0.50, he would not be interested. Being a Venture stock, it is probably very susceptible to news.

other services

Hap (Robert) Sneddon FCSI

Chief Portfolio Manager & Founder

2017-09-14
COMMENT

PHM-X

$0.310

Patient Home Monitoring


Right now, they are waiting for some regulatory information to come back, both from a tax perspective as well as a market perspective, when dealing with the regulators. Once that comes out, then it will go to a shareholder vote to split the company up. Thinks they have turned the corner and have started to execute very well. Have had 3 quarters of growing earnings and generating cash flow and higher revenue. Stock is super cheap.

other services

Bruce Campbell (2)

President & Portfolio Manager

OPTIMISTIC
2017-09-05
COMMENT

PHM-X

$0.330

Patient Home Monitoring


This was a super stock in the beginning. It has the makings of something with new management in the US. Supposedly there is going to be a division of the assets. However, don’t forget, that everything that is in the medical sector is getting Trump-ized, so it is difficult at the moment. There is only one analyst on this, and he keeps giving it a “Buy”.

other services

Michael Smedley

Exec VP & Chief Investment Officer

2017-08-23
DON'T BUY

PHM-X

$0.390

Patient Home Monitoring


Great price momentum.  Valuation is still not there.  It is expensive and there is not a ton of earnings. 

other services

Jason Mann

CIO & Co-Founder

CAUTIOUS
2017-08-22
BUY

PHM-X

$0.450

Patient Home Monitoring


Their last couple of quarters have been a very nice turnaround. It was a big acquisition story. Now things are getting back into control.  He is not big on turnarounds until they have turned around a little further.  If they can put in a couple more quarters they will do much better.  You’ve got some time to buy it.

other services

Peter Hodson

CEO & Head of Research

OPTIMISTIC
2017-08-15
COMMENT

PHM-X

$0.480

Patient Home Monitoring


Has not met the new management. This has 2 different parts, one being in the US.

other services

Michael Smedley

Exec VP & Chief Investment Officer

2017-07-27
DON'T BUY

PHM-X

$0.400

Patient Home Monitoring


They changed their business model over the years, but he is skeptical of it.  There could be regulatory changes.  He feels it is better not to take those excessive risks at this time.

other services

Andrey Omelchak

President & CIO

CAUTIOUS
2017-07-26
TOP PICK

PHM-X

$0.435

Patient Home Monitoring


Continues to grow organically, and has done a phenomenal job. They had the reimbursement cut a year ago, and since that time they have actually gained back all their business and continue to grow. The company is going to be split and are currently in the regulatory process. Still trading at a very cheap valuation, and can go much higher from here. (Analysts’ price target is $0.85.)

other services

Bruce Campbell (2)

President & Portfolio Manager

2017-07-24
BUY

PHM-X

$0.400

Patient Home Monitoring


He would like to see more consistency, but it looks pretty good to him.  It had a rise and fall, but has been rallying recently.

other services

Matt Kacur

President

SELECTIVE
2017-07-24
COMMENT

PHM-X

$0.400

Patient Home Monitoring


This looks pretty good. Reached a peak in 2015 and then went into a tail spin and then had a very low volatility base in the latter part of 2016. It is just now starting to make higher highs and higher lows, which is a good thing.

other services

Keith Richards

Portfolio Manager

CAUTIOUS
2017-07-17
DON'T BUY

PHM-X

$0.380

Patient Home Monitoring


It was in an upward trend and then broke it and is in a downward trend.  It is underperforming the TSX and broke below the 20 & 50 day moving average. 

other services

Don Vialoux

Research Analyst

2017-07-14
COMMENT

PHM-X

$0.380

Patient Home Monitoring


Take some profits or be a buyer? This has contracted a bit again. The main problem is that you don’t really get too much presence of them in the marketplace compared to their beginning. An issue that is difficult to handle is that they are going to split into 2 companies in a few months. When they split, that would suggest that instead of having an itsy-bitsy $.38 stock you are going to have 2 itsy-bitsy $.20 stocks. One is probably going to be dealing with sleep apnea type stuff and the other with the traditional home monitoring, which is still really experimental. He would probably underweight this until he could see the whites of their eyes.

other services

Michael Smedley

Exec VP & Chief Investment Officer

Showing 1 to 15 of 166 entries
<< < 1 2 3 4 5 > >>
Post Comment

1 Comment

idaustin

February 2nd 2016 at 7:44pm

Absolutely amazing that all these experts got sold on the story and believed it all the way down. Expert is Latin for ostrich


You must be logged in to comment.